Drawing for JUVIVE

USPTO serial 88675618

JUVIVE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SCHWARZ, KATHLEEN MICHELLE HUD
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with JUVIVE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lisa W. Rosaya

Lisa W. Rosaya Baker & McKenzie LLP452 Fifth AvenueNEW YORK, NY 10018UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Nutritional supplements, namely, ketone ester beverages for use as a dietary supplement for geroprotection, neuroprotection and cardioprotection; nutraceuticals for use as a dietary supplement for geroprotection, neuroprotection and cardioprotection; medicines, namely, compositions for prevention and treatment of physiological aging, cognitive aging and senescence, and for stimulation of limb and internal organ regeneration; pharmaceuticals, namely, compositions for prevention and treatment of physiological aging, cognitive aging and senescence, and for stimulation of limb and internal organ regenerationACTIVE—
035Business consulting, namely, management of clinical research, trial, and development data for others; Business consulting in the nature of regulatory submission management, namely, assisting others in preparing and filing applications for medical devices, biopharmaceutical, and biotechnological products and software with governmental regulatory bodies; Business consulting services, namely, marketing services in the field of medical, biopharmaceutical, and biotechnological products and software technologiesACTIVE—
036Providing venture capital, development capital, private equity and investment funding in the field of biotechnology, pharmaceuticals, and medical devices and technologiesACTIVE—
042Development of pharmaceutical preparations and medicines; medical and scientific research in the field of human health and aging; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical research and development in the field of protocols and techniques for life extension and prevention of aging, anti-aging pharmaceuticals, anti-aging devices; computer software development in the field of applications for anti-aging and life extension; providing temporary use of online non-downloadable computer programs for cognitive stimulation and training; research in the field of artificial intelligence; conducting clinical research and trials for othersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 1, 2022ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
May 16, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 16, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 1, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 1, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 1, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 1, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 29, 2021EX2GSOU EXTENSION 2 GRANTED—
Sep 29, 2021EXT2SOU EXTENSION 2 FILED—
Sep 29, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 8, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 6, 2021EX1GSOU EXTENSION 1 GRANTED—
Apr 6, 2021EXT1SOU EXTENSION 1 FILED—
Apr 6, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 13, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 26, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 26, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Aug 26, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 26, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 18, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 18, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 29, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 15, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 15, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Jul 15, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 15, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 15, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 17, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 16, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 16, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 17, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 17, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 17, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 16, 2020DOCKASSIGNED TO EXAMINER—
Nov 5, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 4, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance